menu search

Agios pharmaceuticals to present broad set of clinical and translational data in rare blood disorders at 65th ash annual meeting and exposition

– Both Mitapivat Dose Arms Achieved Statistically Significant Hemoglobin Response in Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease...

November 2, 2023, 9:05 am

Siren biotechnology awarded $4m in grant funding from the california institute for regenerative medicine (cirm)

SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) — Siren Biotechnology, a gene therapy company pioneering Universal AAV Immuno-Gene Therapies for Cance...

November 1, 2023, 4:46 pm

Gri bio announces partnership with the respiratory translational research collaboration to advance leading nkt regulation technology targeting earlier in the inflammatory cascade to modulate disease p

UK consortia brings together internationally recognized investigators in the UK’s leading centers of excellence to carry out experimental and early ...

October 17, 2023, 12:35 pm

Sana biotechnology announces increased focus on hypoimmune-related pipeline with the potential to deliver clinical proof of concept data from four programs in 2023 and 2024 with a 2024 operating burn

Increasing focus on ex vivo cell therapy platform based on extensive preclinical and early translational...

October 10, 2023, 8:15 pm

Mink therapeutics to present data update from allogeneic inkt cells in solid tumors at sitc 2023

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discove...

September 27, 2023, 9:05 am

Addex therapeutics to release half-year 2023 financial results and host conference call on august 10, 2023

Geneva, Switzerland, August 3 , 2023 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modu...

August 4, 2023, 1:00 am

Cellectis presents updated clinical and translational data on balli-01 at the european hematology association (eha) 2023

NEW YORK, June 09, 2023 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology c...

June 9, 2023, 8:30 pm

Regeneron pharmaceuticals, inc. (regn) td cowen 4th annual oncology innovation summit (transcript)

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN ) TD Cowen 4th Annual Oncology Innovation Summit May 30, 2023 12:30 PM ET Company Participants Izzy Lowy ...

May 30, 2023, 3:18 pm

Arrowhead pharmaceuticals, inc. (arwr) q2 2023 earnings call transcript

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q2 2023 Earnings Conference Call May 2, 2023 4:30 PM ET Company Participants Vincent Anzalone - Vice Pr...

May 2, 2023, 8:42 pm

Cabaletta bio to present at the american society of gene and cell therapy 26th annual meeting

PHILADELPHIA, May 02, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and la...

May 2, 2023, 4:35 pm

Sana biotechnology announces preclinical data published in science translational medicine showing its hypoimmune pancreatic islet cells evaded allogeneic and autoimmune rejection and controlled type 1

Hypoimmune human islet cells normalized glucose in diabetic humanized immunocompetent mouse model and avoided allogeneic and autoimmune rejection by t...

April 12, 2023, 8:05 pm

Sana biotechnology announces preclinical data published in science translational medicine showing its hypoimmune pancreatic islet cells evaded allogeneic and autoimmune rejection and controlled type 1

Hypoimmune human islet cells normalized glucose in diabetic humanized immunocompetent mouse model and avoided allogeneic and autoimmune rejection by t...

April 12, 2023, 8:05 pm

Predictive oncology appoints translational research leader christoph reinhard to scientific advisory board

Predictive Oncology Inc. (NASDAQ:POAI) announced the appointment of Dr. Christoph Reinhard to its scientific board to serve alongside other key though...

April 4, 2023, 9:34 am

Cue biopharma, inc. (cue) q4 2022 earnings call transcript

Cue Biopharma, Inc. (NASDAQ:CUE ) Q4 2022 Earnings Conference Call March 21, 2023 4:30 PM ET Company Participants Dan Passeri - CEO Matteo Levisetti -...

March 21, 2023, 11:00 pm

Alaunos therapeutics reports fourth quarter and full year 2022 financial results

Generated cutting-edge translational data demonstrating safety, persistence and functionality of infuse...

March 7, 2023, 12:00 pm

Nanostring to webcast panel on ai-based genomics and drug discovery from the 43rd annual cowen health care conference

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and ...

March 1, 2023, 6:00 am

Iovance biotherapeutics, inc. (iova) q4 2022 earnings call transcript

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET Company Participants Sara Pellegrino - Seni...

March 1, 2023, 12:37 am

How abbott labs, abbvie could profit on seizure drug formula

A new study published in Science translational Medicine could introduce a profitable opportunity for ma...

February 17, 2023, 7:02 am

Regeneron pharmaceuticals, inc. (regn) svb securities global biopharma conference (transcript)

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN ) SVB Securities Global Biopharma Conference February 14, 2023 9:20 AM ET Company Participants Ryan Crowe...

February 14, 2023, 3:42 pm

Arrowhead pharmaceuticals, inc. (arwr) q1 2023 earnings call transcript

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q1 2023 Earnings Conference Call February 6, 2023 4:30 PM ET Company Participants Vincent Anzalone - Vi...

February 6, 2023, 9:14 pm


Search within

Pages Search Results: